Protection of mice deficient in mature B cells from West Nile virus infection by passive and active immunization

PLoS Pathogens

Volumn 13, Issue 11, 2017, Pages

  Giordano, Daniela ^a   Draves, Kevin E ^a   Young, Lucy B ^a   Roe, Kelsey ^a   Bryan, Marianne A ^a   Dresch, Christiane ^a   Richner, Justin M ^b   Diamond, Michael S ^a,b   Gale, Michael ^a   Clark, Edward A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; WEST NILE VACCINE; WEST NILE VIRUS ANTI CD 180 CONJUGATE VACCINE; B CELL ACTIVATING FACTOR RECEPTOR; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ACTIVE IMMUNIZATION; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; MALE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; VIRAL PLAQUE ASSAY; VIRUS IMMUNITY; WEST NILE FEVER; WEST NILE VIRUS; ANIMAL; C57BL MOUSE; DEFICIENCY; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; PHYSIOLOGY; VACCINATION; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; VACCINATION; WEST NILE FEVER; WEST NILE VIRUS;

EID: 85036572801     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006743     Document Type: Article

References (74)

1. Vincent FB, Morand EF, Schneider P, Mackay F, (2014) The BAFF/APRIL system in SLE pathogenesis. Nat Rev Rheumatol10: 365–373. doi: 10.1038/nrrheum.2014.33 24614588
2. Mackay F, Schneider P, (2009) Cracking the BAFF code. Nat Rev Immunol9: 491–502. doi: 10.1038/nri2572 19521398
3. Goenka R, Scholz JL, Sindhava VJ, Cancro MP, (2014) New roles for the BLyS/BAFF family in antigen-experienced B cell niches. Cytokine Growth Factor Rev25: 107–113. doi: 10.1016/j.cytogfr.2014.01.001 24507939
4. Treml JF, Hao Y, Stadanlick JE, Cancro MP, (2009) The BLyS family: toward a molecular understanding of B cell homeostasis. Cell Biochem Biophys53: 1–16. doi: 10.1007/s12013-008-9036-1 19034695
5. Wei F, Chang Y, Wei W, (2015) The role of BAFF in the progression of rheumatoid arthritis. Cytokine76: 537–544. doi: 10.1016/j.cyto.2015.07.014 26198030
6. Cerutti A, Puga I, Cols M, (2012) New helping friends for B cells. Eur J Immunol42: 1956–1968. doi: 10.1002/eji.201242594 22865046
7. Rickert RC, Jellusova J, Miletic AV, (2011) Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol Rev244: 115–133. doi: 10.1111/j.1600-065X.2011.01067.x 22017435
8. Hsu BL, Harless SM, Lindsley RC, Hilbert DM, Cancro MP, (2002) Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. J Immunol168: 5993–5996. 12055205
9. Sasaki Y, Casola S, Kutok JL, Rajewsky K, Schmidt-Supprian M, (2004) TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol173: 2245–2252. 15294936
10. Shulga-Morskaya S, Dobles M, Walsh ME, Ng LG, MacKay F, et al. (2004) B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J Immunol173: 2331–2341. 15294946
11. Ng LG, Sutherland AP, Newton R, Qian F, Cachero TG, et al. (2004) B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol173: 807–817. 15240667
12. Tsuji-Kawahara S, Chikaishi T, Takeda E, Kato M, Kinoshita S, et al. (2010) Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice. J Virol84: 6082–6095. doi: 10.1128/JVI.02516-09 20375169
13. Frederico B, May JS, Efstathiou S, Stevenson PG, (2014) BAFF receptor deficiency limits gammaherpesvirus infection. J Virol88: 3965–3975. doi: 10.1128/JVI.03497-13 24501409
14. Xu HC, Huang J, Khairnar V, Duhan V, Pandyra AA, et al. (2015) Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection. J Virol89: 4748–4759. doi: 10.1128/JVI.02976-14 25673724
15. Suthar MS, Diamond MS, Gale M, Jr. (2013) West Nile virus infection and immunity. Nat Rev Microbiol11: 115–128. doi: 10.1038/nrmicro2950 23321534
16. Suthar MS, Pulendran B, (2014) Systems analysis of West Nile virus infection. Curr Opin Virol6: 70–75. doi: 10.1016/j.coviro.2014.04.010 24851811
17. Samuel MA, Diamond MS, (2006) Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol80: 9349–9360. doi: 10.1128/JVI.01122-06 16973541
18. Barzon L, Pacenti M, Sinigaglia A, Berto A, Trevisan M, et al. (2015) West Nile virus infection in children. Expert Rev Anti Infect Ther13: 1373–1386. doi: 10.1586/14787210.2015.1083859 26325613
19. Lazear HM, Diamond MS, (2015) New insights into innate immune restriction of West Nile virus infection. Curr Opin Virol11: 1–6. doi: 10.1016/j.coviro.2014.12.001 25554924
20. Shrestha B, Diamond MS, (2004) Role of CD8+ T cells in control of West Nile virus infection. J Virol78: 8312–8321. doi: 10.1128/JVI.78.15.8312-8321.2004 15254203
21. Sitati EM, Diamond MS, (2006) CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J Virol80: 12060–12069. doi: 10.1128/JVI.01650-06 17035323
22. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M, (2003) B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol77: 2578–2586. doi: 10.1128/JVI.77.4.2578-2586.2003 12551996
23. Diamond MS, Sitati EM, Friend LD, Higgs S, Shrestha B, et al. (2003) A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med198: 1853–1862. doi: 10.1084/jem.20031223 14662909
24. Austin SK, Dowd KA, (2014) B cell response and mechanisms of antibody protection to West Nile virus. Viruses6: 1015–1036. doi: 10.3390/v6031015 24594676
25. Schultz TE, Blumenthal A, (2016) The RP105/MD-1 complex: molecular signaling mechanisms and pathophysiological implications. J Leukoc Biol.
26. Chappell CP, Giltiay NV, Dresch C, Clark EA, (2014) Controlling immune responses by targeting antigens to dendritic cell subsets and B cells. Int Immunol26: 3–11. doi: 10.1093/intimm/dxt059 24285828
27. Chaplin JW, Chappell CP, Clark EA, (2013) Targeting antigens to CD180 rapidly induces antigen-specific IgG, affinity maturation, and immunological memory. J Exp Med210: 2135–2146. doi: 10.1084/jem.20130188 24019553
28. Keller BC, Fredericksen BL, Samuel MA, Mock RE, Mason PW, et al. (2006) Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol80: 9424–9434. doi: 10.1128/JVI.00768-06 16973548
29. Suthar MS, Ma DY, Thomas S, Lund JM, Zhang N, et al. (2010) IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog6: e1000757. doi: 10.1371/journal.ppat.1000757 20140199
30. McKearn JP, Baum C, Davie JM, (1984) Cell surface antigens expressed by subsets of pre-B cells and B cells. J Immunol132: 332–339. 6606670
31. Harada Y, Kawano MM, Huang N, Mahmoud MS, Lisukov IA, et al. (1996) Identification of early plasma cells in peripheral blood and their clinical significance. Br J Haematol92: 184–191. 8562394
32. Shaffer AL, Shapiro-Shelef M, Iwakoshi NN, Lee AH, Qian SB, et al. (2004) XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity21: 81–93. doi: 10.1016/j.immuni.2004.06.010 15345222
33. Bekeredjian-Ding IB, Wagner M, Hornung V, Giese T, Schnurr M, et al. (2005) Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J Immunol174: 4043–4050. 15778362
34. Han JH, Umiker BR, Kazimirova AA, Fray M, Korgaonkar P, et al. (2014) Expression of an anti-RNA autoantibody in a mouse model of SLE increases neutrophil and monocyte numbers as well as IFN-I expression. Eur J Immunol44: 215–226. doi: 10.1002/eji.201343714 24105635
35. Bennett JL, Elhofy A, Charo I, Miller SD, Dal Canto MC, et al. (2007) CCR2 regulates development of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Viral Immunol20: 19–33. doi: 10.1089/vim.2006.0068 17425418
36. Getts DR, Terry RL, Getts MT, Muller M, Rana S, et al. (2008) Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med205: 2319–2337. doi: 10.1084/jem.20080421 18779347
37. Getts DR, Terry RL, Getts MT, Muller M, Rana S, et al. (2012) Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages. J Neuroinflammation9: 246. doi: 10.1186/1742-2094-9-246 23111065
38. Giordano D, Li C, Suthar MS, Draves KE, Ma DY, et al. (2011) Nitric oxide controls an inflammatory-like Ly6C(hi)PDCA1+ DC subset that regulates Th1 immune responses. J Leukoc Biol89: 443–455. doi: 10.1189/jlb.0610329 21178115
39. Engle MJ, Diamond MS, (2003) Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice. J Virol77: 12941–12949. doi: 10.1128/JVI.77.24.12941-12949.2003 14645550
40. Metcalf TU, Baxter VK, Nilaratanakul V, Griffin DE, (2013) Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis. J Virol87: 2420–2429. doi: 10.1128/JVI.01769-12 23255791
41. Kang BS, Palma JP, Lyman MA, Dal Canto M, Kim BS, (2005) Antibody response is required for protection from Theiler's virus-induced encephalitis in C57BL/6 mice in the absence of CD8+ T cells. Virology340: 84–94. doi: 10.1016/j.virol.2005.06.028 16039687
42. Stewart BS, Demarest VL, Wong SJ, Green S, Bernard KA, (2011) Persistence of virus-specific immune responses in the central nervous system of mice after West Nile virus infection. BMC Immunol12: 6. doi: 10.1186/1471-2172-12-6 21251256
43. Ngo VN, Cornall RJ, Cyster JG, (2001) Splenic T zone development is B cell dependent. J Exp Med194: 1649–1660. 11733579
44. Sage AP, Tsiantoulas D, Baker L, Harrison J, Masters L, et al. (2012) BAFF receptor deficiency reduces the development of atherosclerosis in mice—brief report. Arterioscler Thromb Vasc Biol32: 1573–1576. doi: 10.1161/ATVBAHA.111.244731 22426131
45. Rahman ZS, Rao SP, Kalled SL, Manser T, (2003) Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice. J Exp Med198: 1157–1169. doi: 10.1084/jem.20030495 14557413
46. Kovesdi D, Paszty K, Enyedi A, Kiss E, Matko J, et al. (2004) Antigen receptor-mediated signaling pathways in transitional immature B cells. Cell Signal16: 881–889. doi: 10.1016/j.cellsig.2004.01.005 15157667
47. Yada A, Ebihara S, Matsumura K, Endo S, Maeda T, et al. (2003) Accelerated antigen presentation and elicitation of humoral response in vivo by FcgammaRIIB- and FcgammaRI/III-mediated immune complex uptake. Cell Immunol225: 21–32. 14643301
48. Giltiay NV, Chappell CP, Clark EA, (2012) B-cell selection and the development of autoantibodies. Arthritis Res Ther14Suppl 4: S1.
49. Metzler G, Kolhatkar NS, Rawlings DJ, (2015) BCR and co-receptor crosstalk facilitate the positive selection of self-reactive transitional B cells. Curr Opin Immunol37: 46–53. doi: 10.1016/j.coi.2015.10.001 26605835
50. Capolunghi F, Cascioli S, Giorda E, Rosado MM, Plebani A, et al. (2008) CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J Immunol180: 800–808. 18178818
51. Aranburu A, Ceccarelli S, Giorda E, Lasorella R, Ballatore G, et al. (2010) TLR ligation triggers somatic hypermutation in transitional B cells inducing the generation of IgM memory B cells. J Immunol185: 7293–7301. doi: 10.4049/jimmunol.1002722 21078901
52. Mao C, Jiang L, Melo-Jorge M, Puthenveetil M, Zhang X, et al. (2004) T cell-independent somatic hypermutation in murine B cells with an immature phenotype. Immunity20: 133–144. 14975236
53. Han JH, Akira S, Calame K, Beutler B, Selsing E, et al. (2007) Class switch recombination and somatic hypermutation in early mouse B cells are mediated by B cell and Toll-like receptors. Immunity27: 64–75. doi: 10.1016/j.immuni.2007.05.018 17658280
54. Ueda Y, Liao D, Yang K, Patel A, Kelsoe G, (2007) T-independent activation-induced cytidine deaminase expression, class-switch recombination, and antibody production by immature/transitional 1 B cells. J Immunol178: 3593–3601. 17339456
55. Giltiay NV, Chappell CP, Sun X, Kolhatkar N, Teal TH, et al. (2013) Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells. J Exp Med.
56. Jacobs HM, Thouvenel CD, Leach S, Arkatkar T, Metzler G, et al. (2016) Cutting Edge: BAFF Promotes Autoantibody Production via TACI-Dependent Activation of Transitional B Cells. J Immunol196: 3525–3531. doi: 10.4049/jimmunol.1600017 27022196
57. von Bulow GU, van Deursen JM, Bram RJ, (2001) Regulation of the T-independent humoral response by TACI. Immunity14: 573–582. 11371359
58. Borges da Silva H, Fonseca R, Pereira RM, Cassado Ados A, Alvarez JM, et al. (2015) Splenic Macrophage Subsets and Their Function during Blood-Borne Infections. Front Immunol6: 480. doi: 10.3389/fimmu.2015.00480 26441984
59. Garcia de Vinuesa C, O'Leary P, Sze DM, Toellner KM, MacLennan IC, (1999) T-independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci. Eur J Immunol29: 1314–1323. 10229099
60. Daffis S, Suthar MS, Gale M, Jr.Diamond MS, (2009) Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virus. J Innate Immun1: 435–445. doi: 10.1159/000226248 20375601
61. Brandler S, Tangy F, (2013) Vaccines in development against West Nile virus. Viruses5: 2384–2409. doi: 10.3390/v5102384 24084235
62. Uhrlaub JL, Brien JD, Widman DG, Mason PW, Nikolich-Zugich J, (2011) Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis. J Immunol186: 3882–3891. doi: 10.4049/jimmunol.1002799 21339368
63. Pinto AK, Richner JM, Poore EA, Patil PP, Amanna IJ, et al. (2013) A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice. J Virol87: 1926–1936. doi: 10.1128/JVI.02903-12 23221549
64. Jardine JG, Kulp DW, Havenar-Daughton C, Sarkar A, Briney B, et al. (2016) HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen. Science351: 1458–1463. doi: 10.1126/science.aad9195 27013733
65. Suthar MS, Brassil MM, Blahnik G, Gale M, Jr. (2012) Infectious clones of novel lineage 1 and lineage 2 West Nile virus strains WNV-TX02 and WNV-Madagascar. J Virol86: 7704–7709. doi: 10.1128/JVI.00401-12 22573862
66. Linke S, Ellerbrok H, Niedrig M, Nitsche A, Pauli G, (2007) Detection of West Nile virus lineages 1 and 2 by real-time PCR. J Virol Methods146: 355–358. doi: 10.1016/j.jviromet.2007.05.021 17604132
67. Ma DY, Suthar MS, Kasahara S, Gale M, Jr.Clark EA, (2013) CD22 is required for protection against West Nile virus Infection. J Virol87: 3361–3375. doi: 10.1128/JVI.02368-12 23302871
68. Cherrier MV, Kaufmann B, Nybakken GE, Lok SM, Warren JT, et al. (2009) Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. Embo J28: 3269–3276. doi: 10.1038/emboj.2009.245 19713934
69. Goins CL, Chappell CP, Shashidharamurthy R, Selvaraj P, Jacob J, (2010) Immune complex-mediated enhancement of secondary antibody responses. J Immunol184: 6293–6298. doi: 10.4049/jimmunol.0902530 20439912
70. Purtha WE, Myers N, Mitaksov V, Sitati E, Connolly J, et al. (2007) Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur J Immunol37: 1845–1854. doi: 10.1002/eji.200737192 17559174
71. Brien JD, Uhrlaub JL, Nikolich-Zugich J, (2008) West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J Immunol181: 8568–8575. 19050276
72. Giordano D, Draves KE, Li C, Hohl TM, Clark EA, (2014) Nitric oxide regulates BAFF expression and T cell-independent antibody responses. J Immunol193: 1110–1120. doi: 10.4049/jimmunol.1303158 24951820
73. Baumgarth N, (2011) The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol11: 34–46. doi: 10.1038/nri2901 21151033
74. Seder RA, Ahmed R, (2003) Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol4: 835–842. doi: 10.1038/ni969 12942084